AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Kenvue to Report Q2 2025 Earnings on August 7, 2025.
ByAinvest
Friday, Jul 25, 2025 6:47 am ET1min read
Kenvue Inc. will announce its Q2 2025 financial results on August 7, 2025. The company will host a conference call and webcast to discuss the results. Kenvue is the world's largest pure-play consumer health company, with iconic brands such as Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena, and Tylenol.
Kenvue Inc. (NYSE: KVUE), the world's largest pure-play consumer health company, will release its second-quarter 2025 financial results on August 7, 2025, before the market opens. The company will host a conference call and webcast to discuss the results at 8:30 a.m. Eastern Time. Investors can access the conference call by dialing 877-407-8835 from the U.S. or +1 201-689-8779 from international locations. A live webcast will also be available at investors.kenvue.com, with a replay made available after the live event.Kenvue Inc. is known for its iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, and Tylenol®, which are science-backed and recommended by healthcare professionals worldwide. The company's heritage spans over a century, and its mission is to put the power of everyday care into consumers' hands and earn a place in their hearts and homes.
Investors are encouraged to tune in to the conference call and webcast to gain insights into Kenvue Inc.'s financial performance and strategic initiatives for the second quarter of 2025. For more information, visit www.kenvue.com.
References:
[1] https://www.stocktitan.net/news/KVUE/kenvue-to-announce-second-quarter-2025-results-on-august-7-sjutkjr2gepb.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet